These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34277651)

  • 1. The Application of Induced Pluripotent Stem Cells Against Liver Diseases: An Update and a Review.
    Zhang L; Pu K; Liu X; Bae SDW; Nguyen R; Bai S; Li Y; Qiao L
    Front Med (Lausanne); 2021; 8():644594. PubMed ID: 34277651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist c-Met Monoclonal Antibody Augments the Proliferation of hiPSC-derived Hepatocyte-Like Cells and Improves Cell Transplantation Therapy for Liver Failure in Mice.
    Yuan L; Zhang Y; Liu X; Chen Y; Zhang L; Cao J; Li X; Wang M; Wu K; Zhang J; Liu G; Tang Q; Yuan Q; Cheng T; Xia N
    Theranostics; 2019; 9(7):2115-2128. PubMed ID: 31037160
    [No Abstract]   [Full Text] [Related]  

  • 3. [Research advances in hepatocyte-like cells from human induced pluripotent stem cells and their application].
    Cao YY; Zeng X
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):69-72. PubMed ID: 29804367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of human pluripotent stem cell-derived hepatocyte-like cells for drug toxicity screening.
    Takayama K; Mizuguchi H
    Drug Metab Pharmacokinet; 2017 Feb; 32(1):12-20. PubMed ID: 28012798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells.
    Deguchi S; Yamashita T; Igai K; Harada K; Toba Y; Hirata K; Takayama K; Mizuguchi H
    Drug Metab Dispos; 2019 Jun; 47(6):632-638. PubMed ID: 30962288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluripotent Stem Cells to Model Degenerative Retinal Diseases: The RPE Perspective.
    Dalvi S; Galloway CA; Singh R
    Adv Exp Med Biol; 2019; 1186():1-31. PubMed ID: 31654384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells (hiPSC-MSCs) Protect Liver against Hepatic Ischemia/ Reperfusion Injury via Activating Sphingosine Kinase and Sphingosine-1-Phosphate Signaling Pathway.
    Du Y; Li D; Han C; Wu H; Xu L; Zhang M; Zhang J; Chen X
    Cell Physiol Biochem; 2017; 43(2):611-625. PubMed ID: 28934733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure.
    Liu QW; Liu QY; Li JY; Wei L; Ren KK; Zhang XC; Ding T; Xiao L; Zhang WJ; Wu HY; Xin HB
    Stem Cell Res Ther; 2018 Nov; 9(1):321. PubMed ID: 30463600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Generation of Zone-specific Hepatocyte-like Cells from Human Induced Pluripotent Stem Cells for Accurate Prediction of Drug-induced Hepatotoxicity].
    Mitani S
    Yakugaku Zasshi; 2019; 139(12):1509-1512. PubMed ID: 31787637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Disease with Human Inducible Pluripotent Stem Cells.
    Grandy R; Tomaz RA; Vallier L
    Annu Rev Pathol; 2019 Jan; 14():449-468. PubMed ID: 30355153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of hepatocytes from induced pluripotent stem cells derived from human hair follicle mesenchymal stem cells.
    Shi X; Lv S; He X; Liu X; Sun M; Li M; Chi G; Li Y
    Cell Tissue Res; 2016 Oct; 366(1):89-99. PubMed ID: 27053247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
    Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
    Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hiPSC-derived hepatocytes closely mimic the lipid profile of primary hepatocytes: A future personalised cell model for studying the lipid metabolism of the liver.
    Kiamehr M; Alexanova A; Viiri LE; Heiskanen L; Vihervaara T; Kauhanen D; Ekroos K; Laaksonen R; Käkelä R; Aalto-Setälä K
    J Cell Physiol; 2019 Apr; 234(4):3744-3761. PubMed ID: 30146765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of induced pluripotent stem cell derived hepatocytes.
    Hannoun Z; Steichen C; Dianat N; Weber A; Dubart-Kupperschmitt A
    J Hepatol; 2016 Jul; 65(1):182-199. PubMed ID: 26916529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming of HUVECs into induced pluripotent stem cells (HiPSCs), generation and characterization of HiPSC-derived neurons and astrocytes.
    Haile Y; Nakhaei-Nejad M; Boakye PA; Baker G; Smith PA; Murray AG; Giuliani F; Jahroudi N
    PLoS One; 2015; 10(3):e0119617. PubMed ID: 25789622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feeder-free and serum-free production of hepatocytes, cholangiocytes, and their proliferating progenitors from human pluripotent stem cells: application to liver-specific functional and cytotoxic assays.
    Nakamura N; Saeki K; Mitsumoto M; Matsuyama S; Nishio M; Saeki K; Hasegawa M; Miyagawa Y; Ohkita H; Kiyokawa N; Toyoda M; Akutsu H; Umezawa A; Yuo A
    Cell Reprogram; 2012 Apr; 14(2):171-85. PubMed ID: 22384928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient Differentiation of Human Induced Pluripotent Stem Cell (hiPSC) Derived Hepatocyte-Like Cells on hMSCs Feeder.
    Mobarra N; Soleimani M; Kouhkan F; Hesari Z; Lahmy R; Mossahebi-Mohammadi M; Arefian E; Jaafarpour Z; Nasiri H; Pakzad R; Tavakoli R; Pasalar P
    Int J Hematol Oncol Stem Cell Res; 2014 Oct; 8(4):20-9. PubMed ID: 25774264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical differences in toxicity mechanisms in induced pluripotent stem cell-derived hepatocytes, hepatic cell lines and primary hepatocytes.
    Sjogren AK; Liljevald M; Glinghammar B; Sagemark J; Li XQ; Jonebring A; Cotgreave I; Brolén G; Andersson TB
    Arch Toxicol; 2014 Jul; 88(7):1427-37. PubMed ID: 24912781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human induced pluripotent stem cell and nanotechnology-based therapeutics.
    Liu WH; Chang YL; Lo WL; Li HY; Hsiao CW; Peng CH; Chiou SH; Ma HI; Chen SJ
    Cell Transplant; 2015; 24(11):2185-95. PubMed ID: 25299513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.